Mallinckrodt Guts IP Suit Amid Oxide Rival's New Drug App
By Kelly Lienhard · February 13, 2024, 3:08 PM EST
A Delaware federal judge has dismissed 10 of the originally asserted 14 patents in pharmaceutical company Mallinckrodt's claims against a French industrial gas company over a generic version of its pediatric...
To view the full article, register now.